Please use this identifier to cite or link to this item: doi:10.22028/D291-35106
Title: Artificial Extracellular Matrices Containing Bioactive Glass Nanoparticles Promote Osteogenic Differentiation in Human Mesenchymal Stem Cells
Author(s): Kroschwald, Lysann M.
Allerdt, Felix
Bernhardt, Anne
Rother, Sandra
Zheng, Kai
Maqsood, Iram
Halfter, Norbert
Heinemann, Christiane
Möller, Stephanie
Schnabelrauch, Matthias
Hacker, Michael C.
Rammelt, Stefan
Boccaccini, Aldo R.
Hintze, Vera
Language: English
Title: International Journal of Molecular Sciences
Volume: 22
Issue: 23
Publisher/Platform: MDPI
Year of Publication: 2021
Free key words: artificial extracellular matrices
bioactive glass nanoparticles
glycosaminoglycans
mesenchymal stem cells
osteogenic differentiation
DDC notations: 610 Medicine and health
Publikation type: Journal Article
Abstract: The present study analyzes the capacity of collagen (coll)/sulfated glycosaminoglycan (sGAG)-based surface coatings containing bioactive glass nanoparticles (BGN) in promoting the osteogenic differentiation of human mesenchymal stroma cells (hMSC). Physicochemical charac teristics of these coatings and their effects on proliferation and osteogenic differentiation of hMSC were investigated. BGN were stably incorporated into the artificial extracellular matrices (aECM). Oscillatory rheology showed predominantly elastic, gel-like properties of the coatings. The complex viscosity increased depending on the GAG component and was further elevated by adding BGN. BGN-containing aECM showed a release of silicon ions as well as an uptake of calcium ions. hMSC were able to proliferate on coll and coll/sGAG coatings, while cellular growth was delayed on aECM containing BGN. However, a stimulating effect of BGN on ALP activity and calcium deposition was shown. Furthermore, a synergistic effect of sGAG and BGN was found for some donors. Our findings demonstrated the promising potential of aECM and BGN combinations in promoting bone regeneration. Still, future work is required to further optimize the BGN/aECM combination for increasing its combined osteogenic effect.
DOI of the first publication: 10.3390/ijms222312819
Link to this record: urn:nbn:de:bsz:291--ds-351062
hdl:20.500.11880/32139
http://dx.doi.org/10.22028/D291-35106
ISSN: 1422-0067
Date of registration: 6-Jan-2022
Description of the related object: Supplementary Material
Related object: https://www.mdpi.com/1422-0067/22/23/12819/s1
Faculty: M - Medizinische Fakultät
Department: M - Experimentelle und Klinische Pharmakologie und Toxikologie
Professorship: M - Keiner Professur zugeordnet
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
File Description SizeFormat 
ijms-22-12819-v2.pdf3,63 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons